Ensign Peak Advisors
DGX icon

Ensign Peak Advisors’s Quest Diagnostics DGX Stock Holding History

Ensign Peak Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.66M Buy
21,990
+4,593
+26% +$901K 0.01% 578
2026
Q1 		$3.41M Buy
17,397
+1,189
+7% +$231K 0.01% 609
2025
Q4 		$2.81M Sell
16,208
-23,553
-59% -$4.29M 0.01% 640
2025
Q3 		$7.58M Sell
39,761
-8,040
-17% -$1.43M 0.01% 510
2025
Q2 		$8.59M Sell
47,801
-3,321
-6% -$577K 0.01% 513
2025
Q1 		$8.65M Sell
51,122
-2,114
-4% -$347K 0.02% 502
2024
Q4 		$8.03M Buy
53,236
+485
+0.9% +$75.4K 0.01% 530
2024
Q3 		$8.19M Sell
52,751
-660
-1% -$98.6K 0.01% 508
2024
Q2 		$7.31M Buy
53,411
+10,125
+23% +$1.39M 0.01% 530
2024
Q1 		$5.76M Sell
43,286
-1,405
-3% -$182K 0.01% 591
2023
Q4 		$6.16M Sell
44,691
-16,248
-27% -$2.14M 0.01% 568
2023
Q3 		$7.43M Sell
60,939
-6,787
-10% -$904K 0.02% 466
2023
Q2 		$9.52M Sell
67,726
-21,605
-24% -$2.98M 0.02% 425
2023
Q1 		$12.6M Sell
89,331
-23,657
-21% -$3.38M 0.03% 361
2022
Q4 		$17.7M Sell
112,988
-20,363
-15% -$2.93M 0.04% 317
2022
Q3 		$16.4M Sell
133,351
-11,320
-8% -$1.49M 0.04% 297
2022
Q2 		$19.2M Buy
144,671
+4,680
+3% +$638K 0.05% 271
2022
Q1 		$19.2M Sell
139,991
-19,900
-12% -$2.77M 0.04% 310
2021
Q4 		$27.7M Buy
159,891
+62,371
+64% +$9.49M 0.05% 267
2021
Q3 		$14.2M Sell
97,520
-20,280
-17% -$2.97M 0.03% 367
2021
Q2 		$15.5M Buy
117,800
+68,560
+139% +$8.98M 0.03% 355
2021
Q1 		$6.32M Sell
49,240
-36,369
-42% -$4.48M 0.01% 544
2020
Q4 		$10.2M Sell
85,609
-230,166
-73% -$28.1M 0.02% 415
2020
Q3 		$36.2M Sell
315,775
-20,484
-6% -$2.42M 0.09% 186
2020
Q2 		$38.3M Sell
336,259
-19,200
-5% -$2.04M 0.1% 165
2020
Q1 		$28.5M Sell
355,459
-8,800
-2% -$911K 0.1% 163
2019
Q4 		$38.9M Buy
+364,259
New +$38M 0.1% 167

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Ensign Peak Advisors's DGX Position: Q2 2026 in Review

Ensign Peak Advisors increased its Quest Diagnostics (DGX) stake by 26% in Q2 2026, buying an estimated $901K and bringing the position to 21,990 shares worth $4.66M. The position accounts for 0.01% of the portfolio, ranked #578.

Ensign Peak Advisors first reported a position in DGX in Q4 2019 and has held it in 27 quarters since. The position peaked at $38.9M in Q4 2019. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Ensign Peak Advisors held 21,990 shares of Quest Diagnostics worth $4.66M as of Q2 2026.
  • Ensign Peak Advisors bought 4,593 Quest Diagnostics shares in Q2 2026, an estimated $901K.
  • Quest Diagnostics made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #578 holding.
  • Ensign Peak Advisors first reported a position in Quest Diagnostics in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Quest Diagnostics position peaked at $38.9M in Q4 2019.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.